HORIZON-JU-GH-EDCTP3-2024-01-02-two-stage
HORIZON-JU-GH-EDCTP3-2024-01-02-two-stage
Programme: Horizon Europe
3 projects · €35,321,075 total EU contribution (project-level) · 25 participating organizations · 18 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€35,321,075
Countries active
Participant organizations by country (headquarters in CORDIS).
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KEMRI2 projects · KE
- UOXF2 projects · UK
- IFAKARA HEALTH INSTITUTE (IHI)2 projects · TZ
- Centers for Disease Control and Prevention1 projects · US
- CEMTROD1 projects · NG
- CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE1 projects · BF
- EUROPEAN VACCINE INITIATIVE1 projects · DE
- EXPRES2ION1 projects · DK
- GLOBAL HEALTH UGANDA LTD1 projects · UG
- GRAS1 projects · BF
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1 projects · UK
- INSTITUT DE RECHERCHE CLINIQUE DU BENIN (IRCB)1 projects · BJ
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium MVC-2G · 101190695 | HORIZON | €14,999,800 | €822,081 | Details |
R21/M-Malaria vaccine to extend the protection of Post-Discharge Malaria Chemoprevention in children recovering from severe anaemia: a randomised-controlled trial in Malawi, Kenya and Uganda R21-PD · 101190602 | HORIZON | €5,325,102 | €847,812 | Details |
A Multi-stage Malaria Vaccine for Control and Elimination PfVIMT · 101190747 | HORIZON | €14,996,173 | €2,630,544 | Details |